14-day Premium Trial Subscription Try For FreeTry Free
NASDAQ:FPRX
Delisted

Five Prime Therapeutics Stock Price (Quote)

$38.00
+0 (+0%)
At Close: May 27, 2022

Range Low Price High Price Comment
30 days $38.00 $38.00 Friday, 27th May 2022 FPRX stock ended at $38.00. During the day the stock fluctuated 0% from a day low at $38.00 to a day high of $38.00.
90 days $38.00 $38.00
52 weeks $38.00 $38.00

Historical Five Prime Therapeutics prices

Date Open High Low Close Volume
Jul 08, 2021 $38.00 $38.00 $38.00 $38.00 0
Jul 07, 2021 $38.00 $38.00 $38.00 $38.00 0
Jul 06, 2021 $38.00 $38.00 $38.00 $38.00 0
Jul 02, 2021 $38.00 $38.00 $38.00 $38.00 0
Jul 01, 2021 $38.00 $38.00 $38.00 $38.00 0
Jun 30, 2021 $38.00 $38.00 $38.00 $38.00 0
Jun 29, 2021 $38.00 $38.00 $38.00 $38.00 0
Jun 28, 2021 $38.00 $38.00 $38.00 $38.00 0
Jun 25, 2021 $38.00 $38.00 $38.00 $38.00 0
Jun 24, 2021 $38.00 $38.00 $38.00 $38.00 0
Jun 23, 2021 $38.00 $38.00 $38.00 $38.00 0
Jun 22, 2021 $38.00 $38.00 $38.00 $38.00 0
Jun 21, 2021 $38.00 $38.00 $38.00 $38.00 0
Jun 18, 2021 $38.00 $38.00 $38.00 $38.00 0
Jun 17, 2021 $38.00 $38.00 $38.00 $38.00 0
Jun 16, 2021 $38.00 $38.00 $38.00 $38.00 0
Jun 15, 2021 $38.00 $38.00 $38.00 $38.00 0
Jun 14, 2021 $38.00 $38.00 $38.00 $38.00 0
Jun 11, 2021 $38.00 $38.00 $38.00 $38.00 0
Jun 10, 2021 $38.00 $38.00 $38.00 $38.00 0
Jun 09, 2021 $38.00 $38.00 $38.00 $38.00 0
Jun 08, 2021 $38.00 $38.00 $38.00 $38.00 0
Jun 07, 2021 $38.00 $38.00 $38.00 $38.00 0
Jun 04, 2021 $38.00 $38.00 $38.00 $38.00 0
Jun 03, 2021 $38.00 $38.00 $38.00 $38.00 0
Click to get the best stock tips daily for free!

About Five Prime Therapeutics

Five Prime Therapeutics Five Prime Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of protein therapeutics that block cancer and inflammatory disease processes in the United States. The company’s product candidates include FPA008, an antibody that inhibits colony stimulating factor-1 receptor and is in Phase Ia/Ib clinical trials for the treatment of various cancers in combination with nivolumab; and is in Phase I/II... FPRX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT